CN1125134A - Traditional Chinese medicine for reducing blood-lipid and its preparing technology - Google Patents
Traditional Chinese medicine for reducing blood-lipid and its preparing technology Download PDFInfo
- Publication number
- CN1125134A CN1125134A CN 95113605 CN95113605A CN1125134A CN 1125134 A CN1125134 A CN 1125134A CN 95113605 CN95113605 CN 95113605 CN 95113605 A CN95113605 A CN 95113605A CN 1125134 A CN1125134 A CN 1125134A
- Authority
- CN
- China
- Prior art keywords
- medicine
- powder
- lipid
- medicines
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for curing hyperlipoidemia is made up by using the Chinese herbal medicines of fresh crataegus fruit, licorice, red sage root, chrysanthemum flower and ligusticum root, etc as the ingredients of its basic formula and making them pass through a scientific preparation process. Said medicine has the functions of removing food stagnancy and reducing blood-lipid, promoting blood circulation by removing blood stasis and making lipid metabolism implement balance, so that it has the obvious therapeutic effect for reducing blood lipid and blood viscosity in human body, and at the same time it has the duplex cure and prevention actions for resisting atheroscleorsis and regulating endocrine function of patient with obesity or hypertension disease.
Description
Content of the present invention belongs to the preparation technology field of medicine, relates to a kind of Chinese medicine and preparation technology thereof who is used for the treatment of hyperlipemia.
After the people entered person in middle and old age, because the body movement amount reduces, central nervous system, endocrine regulation disorder were higher fatty acid in addition, the excessive absorption of high protein diet and drinks, beverage, and lipid dysbolismus---hyperlipemia takes place easily.In case after the trouble hyperlipemia, the concentration of triglyceride and cholesterol will raise greatly in the blood, the lipid of this high concentration can be attached to the human body artery blood vessel wall, and progressively make its fibrosis, calcification, form atherosis speckle, so make the tremulous pulse hardening that narrows down, progressive or blocking blood flow suddenly, cause myocardial ischemia or blood supply in brain deficiency, even myocardial infarction or cerebral thrombosis, cerebral hemorrhage etc. occur.In recent years, the hypertension, coronary heart disease, atherosclerosis and the obesity person that cause because of hyperlipemia and high blood viscosity among the crowd sharply increase, and in big and medium-sized cities and western countries, this type of patient's sickness rate is then higher.To the treatment of hyperlipemia, with regard to medical science textbook and existing medicine, still not having a kind ofly can all have the Western medicine of significant curative effect to all hyperlipemias, and takes Western medicine for a long time and for human body certain toxic and side effects is arranged; And some Chinese medicine preparation also has limitation to the treatment of primary disease, exists long, many shortcomings such as effect is unstable and cure rate is low course of treatment.
The objective of the invention is to principle, the Chinese traditional medicines depressing lipid that a kind of curative effect height, short treating period is provided and has no side effect according to traditional Chinese medical science treatment must aim at the pathogenesis of disease.
Chinese traditional medicines depressing lipid of the present invention is that the invention designer passes through the summary of relevant medical literature and clinical practice for many years and develop on the basis of further investigation lipid metabolism to obtain, it is to give birth to the mountain wingceltis, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae, Flos Chrysanthemi, Chinese herb medicines such as Rhizoma Chuanxiong are basic recipe, process by science, make it to give full play to the characteristics of Chinese herbs decoction, can reach the removing food stagnancy blood fat reducing, blood circulation promoting and blood stasis dispelling, improve blood circulation, impel lipid metabolism to realize equilibrated purpose, has the obvious treatment effect for reducing blood in human body in fat and blood viscosity, simultaneously for atherosclerosis, the endocrine function of adjusting obesity and patients with hypertension has double treatment and preventive effect.
The basic recipe composition (percentage by weight) that constitutes this Chinese traditional medicines depressing lipid is:
Give birth to mountain wingceltis 15~20% Radix Glycyrrhizaes 15~20%
Radix Salviae Miltiorrhizae 15~20% Flos Chrysanthemis 10~15%
Rhizoma Chuanxiong 10~15% Radix Puerariaes 10~15%
Hirudo 5~10%.Fructus Crataegi in the prescription, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong all have reduction TC (cholesterol), TG (triglyceride), reduce lipid sedimentary effect in blood vessel wall; Flos Chrysanthemi, Radix Puerariae have tangible lipoid peroxidization resistant and strengthen the function of human body immunity; Radix Glycyrrhizae, Hirudo have anticoagulant effect preferably again.All medicines share, and can quicken the picked-up of liver to lipoprotein in the blood by suppressing the synthetic of endogenous cholesterol, promote that cholesterol transforms in liver or the drainage form, realize the balance adjustment of lipid metabolism.
In concrete the enforcement, medicine can be made into blood fat reducing electuary and capsule for descend of blood fat product by the basic recipe composition, its preparation method is as described below.
One, the preparation method of blood fat reducing electuary:
1. clean all medicines of prescription;
2. get Fructus Crataegi amount in the formula components 40%, the Radix Glycyrrhizae amount 40%, 40% and the Hirudo amount of Rhizoma Chuanxiong amount 100%, mix and pulverize the back and cross 100 mesh sieves, it is standby to make the medical material fine powder;
3. get all medicines of residue in the prescription in addition, 4~8 times of amounts of adding distil water were soaked after 30 minutes, boiled and extracted 2 hours, filtered then, and filtrate is deposited in addition; Medicinal residues part after filtering is converted in the distilled water of inserting 3 times of amounts again, boiled and extracted 1 hour, filter once more, and, residual liquid is extruded firmly squeezing of residue; Collect merging extracted twice liquid, leave standstill filtration, be concentrated into the thick paste shape through 80 ℃ of temperature, proportion about 1.5;
4. when the temperature for the treatment of thick paste shape medicine is reduced to 40 ℃ of left and right sides, add 0.2 ‰ saccharin sodium, after the stirring and dissolving, add again, stir and rub and make the shape soft material that sticks together by the prepared medical material fine powder of 2. processes; Soft material is crossed 20 mesh sieves granulate, dry through 60 ℃ of temperature again, at last the medicine grain is sub-packed in the plastics drug bag by every bag 15 gram, make suspension granule.
Two, the preparation method of capsule for descend of blood fat:
1. clean all medicines of prescription;
2. all medicines after will cleaning mix, pulverize, cross 40 mesh sieves, obtain the medicine coarse powder;
3. the medicine coarse powder is adorned percolation vat with 60% ethanol after moistening 24 hours, pour into above 60% ethanol about powder height 2cm in bucket, quiet soaking spent the night;
4. convert with the ethanol liquid of 8 times of medical material total amounts and insert in the quiet medicine that soaks later diafiltration, extraction; Collect ginseng filtrate and reclaim ethanol, it is 1.5 that percolate is concentrated into proportion at normal temperatures, and spray drying obtains fine drug powder;
5. fine drug powder is incapsulated, every capsule grain contains medicated powder 0.4 gram, and per 60 is one bottle (box).
Case observation and curative effect:
Clinical case 80 examples (58 of men, 22 of woman) of observing altogether, the age, wherein hypercholesterolemia 23 examples accounted for 28.25% between 33~74 years old, and hypertriglyceridemia 57 examples account for 71.75%.
1. clinical symptoms: dizzy headache, feeling of oppression and pain in the chest, limbs fatigue, nervously breathe hard, abdominal distention poor appetite, stool are uncomfortable, light red tongue, greasy fur, stringy and rolling pulse or sliding number.
2. medicining mode: electuary every day 2~3 times, each a bag.Capsule every day 2~3 times, each two.Be 15 days a course of treatment.
3. criterion of therapeutical effect:
A. disease efficacy evaluation: symptom disappears substantially or transfers produce effects significantly well to; Symptom and picture of the tongue, pulse condition change to taking a turn for the better; Symptom and picture of the tongue, pulse condition no change are invalid.
B. hold and see index evaluation: by taking blood fat reducing electuary (capsule) after 15 days, TC drop-out value>50% is a produce effects; Drop-out value is effective 20~40%; Drop-out value<10% item is invalid; TG drop-out value>50% is a produce effects; Drop-out value is effective 20~30%; Drop-out value<20% is invalid.
4. curative effect: this organizes 80 routine case histories after treatment, produce effects 76 examples, effective 3 examples, invalid 1 example, and total effective rate is 98.75%, obvious effective rate is 95%.
Claims (3)
1, a kind of Chinese medicine that is used for the treatment of hyperlipemia, the formula components (percentage by weight) that it is characterized in that constituting this medicine is:
Fructus Crataegi 15~20% Radix Glycyrrhizaes 15~20%
Radix Salviae Miltiorrhizae 15~20% Flos Chrysanthemis 10~15%
Rhizoma Chuanxiong 10~15% Radix Puerariaes 10~15%
Hirudo 5~10%
2, according to the technology of the described formulation blood fat reducing of claim 1 electuary, it is characterized in that comprising following preparation process:
2.1 clean all medicines of prescription;
2.2 get in the formula components give birth to mountain wingceltis amount 40%, the Radix Glycyrrhizae amount 40%, 40% and the Hirudo amount of Rhizoma Chuanxiong amount 100%, mix and pulverize the back and cross 100 mesh sieves, it is standby to make the medical material fine powder;
2.3 get all medicines of residue in the prescription in addition, 4~8 times of amounts of adding distil water were soaked after 30 minutes, boiled and extracted 2 hours, filtered then, filtrate is deposited in addition; Medicinal residues part after filtering is converted in the distilled water of inserting 3 times of amounts again, boiled and extracted 1 hour, filter once more, and, residual liquid is extruded firmly squeezing of residue; Collect merging extracted twice liquid, leave standstill filtration, be concentrated into the thick paste shape through 80 ℃ of temperature, proportion about 1.5;
2.4 treat to reduce to about 40 ℃ through the medicine temperature after 2.3 processes, add 0.2% saccharin sodium, after the stirring and dissolving, add again by the prepared medical material fine powder of 2.2 processes, stir and rub and make the landform soft material; Soft material is crossed 20 mesh sieves granulate, dry through 60 ℃ of temperature again, at last the medicine grain is sub-packed in the plastics drug bag by every bag 15 gram.
3, according to the technology of the described formulation capsule for descend of blood fat of claim 1 agent, it is characterized in that comprising following preparation process:
3.1 clean all medicines of prescription;
3.2 all medicines after will cleaning mix, pulverize, cross 40 mesh sieves, obtain the medicine coarse powder;
3.3 the medicine coarse powder is adorned percolation vat with 60% ethanol after moistening 24 hours, in bucket, to pour into above 60% ethanol about powder height 2cm, quiet soaking spent the night;
3.4 will convert diafiltration in the ethanol liquid of inserting 8 times of medical material total amounts, extraction through the medicine after 3.3 processes; Collect percolate and reclaim ethanol, it is 1.5 that percolate is concentrated into proportion at normal temperatures, and spray drying obtains fine drug powder;
3.5 fine drug powder is incapsulated, and every capsule grain contains medicated powder 0.4 gram, every bottle (box) 60.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95113605A CN1056287C (en) | 1995-07-05 | 1995-07-05 | Traditional Chinese medicine for reducing blood-lipid and its preparing technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95113605A CN1056287C (en) | 1995-07-05 | 1995-07-05 | Traditional Chinese medicine for reducing blood-lipid and its preparing technology |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1125134A true CN1125134A (en) | 1996-06-26 |
CN1056287C CN1056287C (en) | 2000-09-13 |
Family
ID=5079995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95113605A Expired - Fee Related CN1056287C (en) | 1995-07-05 | 1995-07-05 | Traditional Chinese medicine for reducing blood-lipid and its preparing technology |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1056287C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1070375C (en) * | 1997-09-15 | 2001-09-05 | 武汉博海生物工程有限公司 | Emulsion for lowering blood-lipid, and method for preparing same |
CN1102064C (en) * | 1999-11-08 | 2003-02-26 | 吉玲 | Chinese medicine for lowering blood pressure |
CN100522197C (en) * | 2006-06-23 | 2009-08-05 | 陕西香菊药业集团有限公司 | Chinese-medicinal preparation for treating high blood fat and its making method |
US8071141B2 (en) * | 2000-12-12 | 2011-12-06 | Kaneka Corporation | Compositions for preventing or ameliorating multiple risk factor syndromes |
CN110840971A (en) * | 2019-11-25 | 2020-02-28 | 安徽科门生物科技有限公司 | Weight-reducing and face-beautifying medicine and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1103302A (en) * | 1993-12-01 | 1995-06-07 | 董兴武 | Hypolipemic and heart tonifying capsule and preparing process thereof |
-
1995
- 1995-07-05 CN CN95113605A patent/CN1056287C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1070375C (en) * | 1997-09-15 | 2001-09-05 | 武汉博海生物工程有限公司 | Emulsion for lowering blood-lipid, and method for preparing same |
CN1102064C (en) * | 1999-11-08 | 2003-02-26 | 吉玲 | Chinese medicine for lowering blood pressure |
US8071141B2 (en) * | 2000-12-12 | 2011-12-06 | Kaneka Corporation | Compositions for preventing or ameliorating multiple risk factor syndromes |
CN100522197C (en) * | 2006-06-23 | 2009-08-05 | 陕西香菊药业集团有限公司 | Chinese-medicinal preparation for treating high blood fat and its making method |
CN110840971A (en) * | 2019-11-25 | 2020-02-28 | 安徽科门生物科技有限公司 | Weight-reducing and face-beautifying medicine and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1056287C (en) | 2000-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103656238A (en) | Traditional Chinese medicine composition for treating rheumatic bone diseases | |
CN104689232A (en) | Traditional Chinese medicine composition for adjusting cardiovascular and cerebrovascular diseases | |
CN101890124A (en) | Chinese medicinal health care product with blood fat reduction effect | |
CN1275634C (en) | Health tea capable of reducing blood lipid, blood viscosity and blood pressure | |
CN1857572A (en) | Hypolipidemic health article and its preparing method | |
CN1056287C (en) | Traditional Chinese medicine for reducing blood-lipid and its preparing technology | |
CN1376480A (en) | Oral liquid | |
CN1053189A (en) | The preparation method of " promoting blood circulation and restoring paralysis pills " | |
CN1443549A (en) | Medicine for preventing injury from producing scar | |
CN109674704A (en) | A kind of Chinese medicine bathing antibacterial liquid/particle improving damp-heat constitution and preparation and application method | |
CN101664518B (en) | Moist bath lotion composition, preparation method and application in preparing pharmaceuticals and health products for treating YIN-blood deficiency fatigue syndrome or adiposity | |
CN101293069B (en) | Traditional Chinese medicine for treating sub-health | |
CN1169546C (en) | Chinese medicine for treating hypotension | |
CN101336998A (en) | Traditional Chinese medicine for treating whelk | |
CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
CN104524397A (en) | Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition | |
CN1183969A (en) | Chinese medicine for diabetes and its production process | |
CN100413521C (en) | Health product for reducing blood fat, and preparation method | |
CN1233409C (en) | Combination of Chinese traditional medicine for health preservation and preparation method | |
CN1136443A (en) | Medicine for defatting | |
CN105055909A (en) | Pharmaceutical/food resource health product capable of preventing and treating presbyopia and preparation method thereof | |
CN1149491A (en) | Traditional Chinese medicine spray preparation for curing and clearing oral peculiar smell and its making technology | |
CN101884758A (en) | Food therapy preparation for preventing and treating cerebrovascular diseases based on theories of preventive treatment of disease and medicine food homology | |
CN1377678A (en) | Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method | |
CN1070073C (en) | Medicine for treating hypercoagulable blood and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |